文献速递肿瘤 PET/CT

儿童恶性肿瘤患者半剂量[18F]-FDG全身PET/CT显像评估

Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-07-05

回顾性纳入100例接受半剂量[18F]-FDG(1.85 MBq/kg)全身PET/CT的儿童肿瘤患者,将600秒采集数据拆分为300、180、60、40、20秒重建。G600、G300、G180、G60组整体图像质量评分为4.9±0.2、4.9±0.3、4.4±0.5、3.5±0.5分,60秒半剂量仍可维持足够图像质量与病灶可见性。

要点

  • 半剂量1.85 MBq/kg全身PET/CT在儿童肿瘤患者中可获得足够图像质量与病灶可见性,估计全身有效剂量1.76-2.57 mSv。
  • 半剂量60秒采集图像质量评分为3.5±0.5分,所有半剂量图像识别的病灶均可在G60图像中定位。
  • 随采集时间缩短本底SUVmax与SD逐渐升高,TBR在各组间差异无统计学意义(均p>0.1)。

核心结论

  • 半剂量[18F]-FDG(1.85 MBq/kg,估计全身有效剂量1.76-2.57 mSv)全身PET/CT在儿童患者中表现良好,图像质量足够且病灶可见性好;半剂量下60秒快速扫描仍可维持足够图像质量与病灶可见性。

研究设计与样本

  • 回顾性纳入100例接受uEXPLORER全身PET/CT、注射真实半剂量[18F]-FDG(1.85 MBq/kg)的儿童肿瘤患者。
  • PET图像先以完整600秒数据重建,再拆分为300秒、180秒、60秒、40秒、20秒组(G600至G20)。
  • 主观分析采用5点Likert量表,客观指标包括本底SUVmax、SUVmean、SD、SNR及SNRnorm,并计算病灶SUVmean、SUVmax与TBR的变异性。

主要发现

  • G600、G300、G180、G60组整体图像质量评分分别为4.9±0.2、4.9±0.3、4.4±0.5、3.5±0.5分。
  • 半剂量图像识别的全部病灶均可在G60图像中定位,G20图像中56%的病灶可清晰识别。
  • 随采集时间缩短,本底SUVmax与SD逐渐升高,TBR在各组间差异无统计学意义(均p>0.1)。
  • 以半剂量图像为参考,病灶SUVmax变异性从G180至G20图像逐渐增加,而病灶SUVmean在各年龄组间保持稳定。
  • SNRnorm与年龄呈高度负相关。

关键数值与推荐

  • 半剂量[18F]-FDG为1.85 MBq/kg,估计全身有效剂量1.76-2.57 mSv。
  • 整体图像质量评分:G600组4.9±0.2分、G300组4.9±0.3分、G180组4.4±0.5分、G60组3.5±0.5分。
  • TBR在各采集时间组间差异无统计学意义(均p>0.1)。
  • G20图像中56%的病灶可清晰识别。

临床怎么用

  • 原文结论认为半剂量[18F]-FDG全身PET/CT在儿童患者中图像质量足够、病灶可见性好。
  • 原文结论认为半剂量下60秒快速扫描仍可维持足够图像质量与病灶可见性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the impact of a true half dose of [18F]-FDG on image quality in pediatric oncological patients undergoing total-body PET/CT and investigate short acquisition times with half-dose injected activity. METHODS: One hundred pediatric oncological patients who underwent total-body PET/CT using the uEXPLORER scanner after receiving a true half dose of [18F]-FDG (1.85 MBq/kg) were retrospectively enrolled. The PET images were first reconstructed using complete 600-s data and then split into 300-s, 180-s, 60-s, 40-s, and 20-s duration groups (G600 to G20). The subjective analysis was performed using 5-point Likert scales. Objective quantitative metrics included the maximum standard uptake value (SUVmax), SUVmean, standard deviation (SD), signal-to-noise ratio (SNR), and SNRnorm of the background. The variabilities in lesion SUVmean, SUVmax, and tumor-to-background ratio (TBR) were also calculated. RESULTS: The overall image quality scores in the G600, G300, G180, and G60 groups were 4.9 ± 0.2, 4.9 ± 0.3, 4.4 ± 0.5, and 3.5 ± 0.5 points, respectively. All the lesions identified in the half-dose images were localized in the G60 images, while 56% of the lesions could be clearly identified in the G20 images. With reduced acquisition time, the SUVmax and SD of the backgrounds were gradually increased, while the TBR values showed no statistically significant differences among the groups (all p > 0.1). Using the half-dose images as a reference, the variability in the lesion SUVmax gradually increased from the G180 to G20 images, while the lesion SUVmean remained stable across all age groups. SNRnorm was highly negatively correlated with age. CONCLUSION: Total-body PET/CT with a half dose of [18F]-FDG (1.85 MBq/kg, estimated whole-body effective dose: 1.76-2.57 mSv) achieved good performance in pediatric patients, with sufficient image quality and good lesion conspicuity. Sufficient image quality and lesion conspicuity could be maintained at a fast scanning time of 60 s with half-dose activity.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chen W, Liu L, Li Y, et al. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG. Eur J Nucl Med Mol Imaging. 2022. PMID: 35788704. doi:10.1007/s00259-022-05893-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。